Skybound Medtech is a Houston-based medical technology company developing dual-use biomedical platforms for both spaceflight and terrestrial medicine. It works on the physiological barriers that limit long-duration human presence off-planet - musculoskeletal, neuro-ocular, immune, and genomic degradation - and builds platform technologies, medical devices, digital-health tools, and medical-manufacturing capability against them. The company positions Houston as its base because it co-locates the Texas Medical Center, NASA's Johnson Space Center, and venture capital. Founder and CEO Matthew Kuhn has said the company intends to launch ten dual-use medtech spinouts over the next decade.